Gabapentin, Dexamethasone, Paracetamol and Ketorolac combination for pain relief and opioid sparing effects in modified radical mastectomy
Not Applicable
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2024/02/062614
- Lead Sponsor
- Parin Lalwani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of ASA physical status I and II posted for elective Modified Radical Mastectomy
Exclusion Criteria
1. Patient refusal
2. Known allergy to the drug
3. H /O gastric or duodenal ulcer
4. H/O Asthma
5. H/O Diabetes mellitus
6. Pregnancy
7. Chronic analgesic or steroid or opioid consumption
8. Patient who is already on gabapentin or any other antiepileptic drugs or antidepressant or benzodiazepines
9. Impaired kidney and liver function
10. BMI >30
11. Limitations in understanding use of PCA pump
12. H/O Migraine or Chronic Pain
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method